Skip to main content
. 2018 Sep 27;293(46):17906–17916. doi: 10.1074/jbc.RA118.004510

Figure 4.

Figure 4.

Activity of BtCDH against various chondroitin sulfate oligosaccharides. Substrates (1 mg/ml each) were treated with 0.5 μm of BtCDH (shown as DPx +, with x being the number of constituent monosaccharides) overnight or diluted in equivalent volume of buffer as control (DPx). HPAEC chromatograms show major shifts in the signals of sulfated DP10 and DP12 oligosaccharides following treatment, accompanied by the appearance of a strong signals for the Δ4,5UA-GalNAc disaccharide in each case.